Researchers at the Case Western Reserve University School Medicine have found that combining two cancer drugs can be effective in treating a specific type of colorectal cancer, according to a new study published in Nature ...
May 2, 2022
0
99
A team of scientists at the Yale Schools of Medicine and Public Health has identified a remdesivir-resistant variant of SARS-CoV-2, the virus that causes COVID-19, in an immunocompromised patient who was being treated with ...
Mar 23, 2022
0
131
A Ludwig Cancer Research study has identified and preclinically validated combination treatments for the brain metastases of breast cancer, a common and typically lethal manifestation of the malignancy. The combination therapy, ...
Oct 18, 2021
0
31
In a study in mice and human cells, Johns Hopkins Medicine researchers say that they have developed a tiny, yet effective method for preventing premature birth. The vaginally-delivered treatment contains nanosized (billionth ...
Jan 13, 2021
0
35
Patients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers that can be aggressive when they develop—and, in many cases, resistant to lifesaving drugs. Now scientists at The University of ...
Sep 22, 2020
0
30
For the first time, scientists have developed a novel and rapid way to test whether the most common and lethal form of malaria is resistant to potent artemisinin drugs.
Sep 10, 2013
0
0
Combination treatments with two or more blood pressure drugs can significantly reduce blood pressure in patients taking ibrutinib, according to a new study published in Blood Advances.
Feb 5, 2024
0
0
A newly-developed heart failure device and medication combination is safe and effective to use, and will allow patients to receive treatment from the comfort of their own home.
Nov 27, 2023
0
1
Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded to immunotherapy (pembrolizumab) alone, suggesting that many patients could avoid the risk for toxicity from combination ...
Apr 17, 2023
0
2
A new combination drug treatment has shown promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.
Mar 28, 2023
0
2
